Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the ...

With weight loss drugs taking the world by storm, more people are exploring adding these medical marvels to their toolkits.

Discontinuing obesity medicines often means the weight comes back and people lose the cardiovascular and metabolic benefits ...

GLP-1 weight-loss pills appear to be just as effective as injections, with clinical trials showing similar average weight ...

Microdosing GLP-1 weight loss drugs like semaglutide is trendy, with supporters touting benefits such as lower costs and potentially fewer side effects. But some doctors are skeptical, calling it ...

There’s no sign of GLP-1s slowing down anytime soon, especially now that they have the support of top-notch athletes.

Retailer offerings trumpet a variety of claims about protein, fat and fibre levels, while some seem to simply be smaller ...

The GLP-1 moment signals how quickly a high-demand therapy can upend established care patterns—and how similar innovations ...

The sustainability of weight-loss drugs is under scrutiny as new research shows that people who stop taking glucagon-like ...

The discovery of GLP-1 and its role in regulating blood glucose was a major scientific breakthrough in diabetes research, yet turning this peptide hormone into an effective medication was no easy task ...

Discover the top five ingredient trends driving GLP-1 innovation in the food and beverage industry. From proteins and fibers ...